Detection of efflux pump activity among clinical isolates of Staphylococcus and Micrococcus species
dc.contributor.author | Adeluola, A.O. | |
dc.contributor.author | Oyedeji, K.S. | |
dc.contributor.author | Mendie, U.E. | |
dc.contributor.author | Johnson, J.R. | |
dc.contributor.author | Porter, J.R. | |
dc.date.accessioned | 2020-01-07T08:18:49Z | |
dc.date.available | 2020-01-07T08:18:49Z | |
dc.date.issued | 2017-11 | |
dc.description | Staff publications | en_US |
dc.description.abstract | Purpose: To detect efflux pump activity (EPA) and screening a suspected efflux pump inhibitor (EPI) [1(3-(trifluoromethyl)benzyl]-piperazine (TFMBP)], which could help in reducing multi-drug resistance (MDR). Methods: Eighteen isolates, viz, 14 S. aureus, 2 S. lentus, 1 S. xylosus and 1 Micrococcus species from various hospital infections of admitted patients were screened for antibiotics susceptibility to 11 classes of antibiotics including oxacillin and β-lactamase production. Efflux pump activity (EPA) was determined by minimum inhibitory concentration (MIC) technique in the presence and absence of TFMBP, the isolates were also screened for MDR genes. Results: All the isolates were resistant to ampicillin (10 µg) and penicillin (10 µg), but sensitive to bacitracin (10 µg). Majority of the isolates were MDR 12/18 (66.7 %), 10 (55.6 %) were inducible βlactamase producers and 3 (16.7 %) were intrinsic β-lactamase producers. Seven (38.9 %) were resistant to oxacillin and also produced carbapenemase enzyme. Eight (66.7 %) of the 12 MDR isolates gave evidence of EPA with TFMBP. However, no MDR genes were detected. Conclusion: Staphylococcus and Micrococcus species exhibit EPA in antibiotic resistance while a suitable EPI such as TFMBP when combined with specific antibiotics could help combat this menace. | en_US |
dc.identifier.citation | Adeluola, A. O., Oyedeji, K. S., Mendie, U. E., Johnson, J. R., & Porter, J. R. (2017). Detection of efflux pump activity among clinical isolates of Staphylococcus and Micrococcus species. Tropical Journal of Pharmaceutical Research, 16(11), 2697-2704. | en_US |
dc.identifier.issn | 1596-9827 | |
dc.identifier.uri | https://ir.unilag.edu.ng/handle/123456789/7295 | |
dc.language.iso | en | en_US |
dc.publisher | Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria. | en_US |
dc.relation.ispartofseries | Tropical Journal of Pharmaceutical Research;Vol.16(11) | |
dc.subject | [1-(3-(Trifluoromethyl)benzyl]-piperazine | en_US |
dc.subject | Efflux pump activity | en_US |
dc.subject | Oxacilline resistant S. aureus | en_US |
dc.subject | Multidrug resistant | en_US |
dc.subject | Carbapenemase | en_US |
dc.subject | Research Subject Categories::PHARMACY::Pharmaceutics | en_US |
dc.title | Detection of efflux pump activity among clinical isolates of Staphylococcus and Micrococcus species | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Detection of EPA among Staphylococcus and Micrococcus.pdf
- Size:
- 207.99 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: